MannKind Corp. (MNKD)
3.75
-0.04
(-1.06%)
USD |
NASDAQ |
Sep 11, 16:00
3.76
+0.01
(+0.27%)
After-Hours: 20:00
MannKind Price : 3.75 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 3.83 | 3.85 | 3.73 | 3.75 | 2.470M |
| Sep 10, 2026 | 3.90 | 3.90 | 3.76 | 3.79 | 3.210M |
| Sep 09, 2026 | 4.155 | 4.36 | 3.92 | 3.94 | 5.193M |
| Sep 08, 2026 | 4.00 | 4.32 | 4.00 | 4.16 | 4.931M |
| Sep 04, 2026 | 3.92 | 4.095 | 3.92 | 4.06 | 2.808M |
| Sep 03, 2026 | 4.05 | 4.07 | 3.96 | 3.96 | 2.331M |
| Sep 02, 2026 | 3.965 | 4.09 | 3.965 | 4.04 | 2.591M |
| Sep 01, 2026 | 3.97 | 4.025 | 3.95 | 3.98 | 2.235M |
| Aug 31, 2026 | 3.94 | 4.02 | 3.90 | 4.01 | 2.806M |
| Aug 28, 2026 | 4.06 | 4.075 | 3.93 | 3.95 | 1.990M |
| Aug 27, 2026 | 4.05 | 4.12 | 4.04 | 4.06 | 2.069M |
| Aug 26, 2026 | 4.16 | 4.19 | 4.05 | 4.09 | 1.766M |
| Aug 25, 2026 | 4.10 | 4.235 | 4.10 | 4.16 | 3.194M |
| Aug 24, 2026 | 4.13 | 4.14 | 4.06 | 4.07 | 2.812M |
| Aug 21, 2026 | 4.28 | 4.355 | 4.11 | 4.15 | 3.205M |
| Aug 20, 2026 | 4.35 | 4.36 | 4.135 | 4.26 | 3.416M |
| Aug 19, 2026 | 4.10 | 4.40 | 4.10 | 4.395 | 5.435M |
| Aug 18, 2026 | 3.87 | 4.10 | 3.87 | 4.07 | 4.601M |
| Aug 17, 2026 | 3.85 | 3.94 | 3.804 | 3.90 | 3.322M |
| Aug 14, 2026 | 3.74 | 3.85 | 3.69 | 3.85 | 2.855M |
| Aug 13, 2026 | 3.88 | 3.895 | 3.63 | 3.73 | 5.240M |
| Aug 12, 2026 | 3.86 | 3.92 | 3.835 | 3.85 | 3.056M |
| Aug 11, 2026 | 3.91 | 3.98 | 3.815 | 3.84 | 4.498M |
| Aug 10, 2026 | 4.065 | 4.08 | 3.88 | 3.93 | 4.157M |
| Aug 07, 2026 | 3.91 | 4.15 | 3.854 | 4.11 | 5.048M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| United Therapeutics Corp. | 497.11 |
| ACADIA Pharmaceuticals, Inc. | 27.83 |
| Gilead Sciences, Inc. | 143.72 |
| Vertex Pharmaceuticals, Inc. | 515.44 |
| Ocugen, Inc. | 1.02 |
Price Related Metrics
| PS Ratio | 2.945 |
| Earnings Yield | -3.78% |
| Market Cap | 1.162B |
| Operating PE Ratio | 87.27 |